Chinese Journal of Organic Chemistry ›› 2023, Vol. 43 ›› Issue (8): 2961-2967.DOI: 10.6023/cjoc202301029 Previous Articles     Next Articles

[RuCl(p-cymene)-(S)-BINAP]Cl催化不对称合成反式-3-氨基-双环[2.2.2]辛烷-2-甲酸乙酯

周章涛, 王杨, 程冰心, 叶伟平*()   

  1. 深圳市华先医药科技有限公司 广东深圳 518118
  • 收稿日期:2023-01-31 修回日期:2023-03-14 发布日期:2023-04-26
  • 基金资助:
    深圳市科技计划(KQTD20190929172447117)

[RuCl(p-cymene)-(S)-BINAP]Cl Catalyzed Asymmetric Preparation of trans-3-Amino-bicyclo[2.2.2]octane-2-carboxylic Acid Ethyl Ester

Zhangtao Zhou, Yang Wang, Bingxin Cheng, Weiping Ye()   

  1. Shenzhen HwaGen Pharmacuticial Co., Ltd, Shenzhen, Guangdong 518118
  • Received:2023-01-31 Revised:2023-03-14 Published:2023-04-26
  • Contact: *E-mail: weiping.ye@rafflespt.com
  • Supported by:
    The Shenzhen Science and Technology Program(KQTD20190929172447117)

trans-3-Amino-bicyclo[2.2.2]octane-2-carboxylic acid ester is the key common chiral fragment of some novel antiviral drugs (like Pimodivir and ZSP1273), which targets the PB2 subunit of RNA polymerase. Now, the market demand of this molecule is at level of hundreds kilograms to tons, and there are several related innovative drugs in clinical study. Here a asymmetric transfer hydrogenation strategy to directly construct trans-3-amino-bicyclo[2.2.2]octane-2-carboxylic acid ethyl ester using [RuCl(p-cymene)-(S)-BINAP]Cl as catalyst with excellent enantioselectivity (over 98% ee) and without tautomerization and protecting/de-protecting process is developed, which holds the potential of scale up production and commercial value.

Key words: influenza, Ru catalysis, asymmetric transfer hydrogenation, β-amino acid ester